Loading clinical trials...
Loading clinical trials...
The objective is to compare the efficacy and safety of masitinib at 12 mg/kg/day to sunitinib at 50 mg/day in the treatment of patients with gastro-intestinal stromal tumor (GIST) after progression wi...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
AB Science
NCT06326346 · Gastrointestinal Stromal Tumors
NCT05493215 · Gastrointestinal Stromal Tumors
NCT07411118 · Small Size Gastrointestinal Stromal Tumors, GIST
NCT05385549 · Gastrointestinal Stromal Tumors
NCT06431451 · Gastrointestinal Stromal Tumors
Washington University School of Medicine
St Louis, Missouri
Institut Bergonié
Bordeaux
Hôpital l'Archet 2- Service de Cancérologie Digestive
Nice
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions